Abstract

<b>Background:</b> Since low diffusing capacity of the lung for carbon monoxide (D<sub>LCO</sub>) is known as a strong risk factor for exacerbation in chronic obstructive pulmonary disease (COPD), D<sub>LCO</sub> or a transfer coefficient (K<sub>CO</sub>) is speculated to also be associated with the risk of exacerbations in asthma–COPD overlap (ACO). <b>Aims and objectives:</b> To assess the clinical usefulness of D<sub>LCO</sub> and K<sub>CO</sub> in predicting future exacerbations among ACO patients. <b>Methods:</b> This study was conducted as an observational cohort survey. D<sub>LCO</sub> and K<sub>CO</sub> were measured in 90 patients with ACO aged ≥ 40 years. Multivariable-adjusted hazard ratios (HRs) for the exacerbation-free rate over one year were estimated and compared across the levels of D<sub>LCO</sub> and K<sub>CO</sub>. <b>Results:</b> Low K<sub>CO</sub> (&lt; 80% per predicted) was positively associated with the incidence of exacerbation (multivariable-adjusted HR = 3.71 (95% confidence interval 1.32–10.39)). The association between low D<sub>LCO</sub> (&lt; 80% per predicted) and exacerbations showed similar trends, although it failed to reach statistical significance (multivariable-adjusted HR = 1.31 (95% confidence interval 0.55–3.11)). <b>Conclusions:</b> Low K<sub>CO</sub> was a significant risk factor for exacerbations among patients with ACO.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.